Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab for Fibromyalgia Pain
NCT06411067Phase 3Withdrawn
- Sponsor
- Naval Medical Center Portsmouth
- Start
- Feb 2020
- Primary completion
- May 2022
- Countries
- 1
01
Overview
A Phase 3 trial of erenumab in fibromyalgia (FM), sponsored by Naval Medical Center Portsmouth. Planned start Feb 2020; status: withdrawn.
02
Drugs
erenumab
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT06411067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411067.